Novartis acquires all rights of Ofatumumab from GSK for $1b
BASEL: Swiss drug manufacturer Novartis has entered into a $1 billion deal to acquire all remaining rights to multiple sclerosis ...
Tag: Novartis acquires all rights of Ofatumumab from GSK for $1b
Novartis acquires all rights of Ofatumumab from GSK for $1b
BASEL: Swiss drug manufacturer Novartis has entered into a $1 billion deal to acquire all remaining rights to multiple sclerosis ...
